| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Oest-rel_rcp | 1.86e-05 | 3 | 47 | 2 | IPR027289 | |
| Domain | Oest_rcpt/oest-rel_rcp | 6.17e-05 | 5 | 47 | 2 | IPR024178 | |
| Domain | Adcy_conserved_dom | 9.24e-05 | 6 | 47 | 2 | IPR009398 | |
| Domain | DUF1053 | 9.24e-05 | 6 | 47 | 2 | PF06327 | |
| Domain | AC_N | 1.72e-04 | 8 | 47 | 2 | IPR032628 | |
| Domain | Adcy | 1.72e-04 | 8 | 47 | 2 | IPR030672 | |
| Domain | AC_N | 1.72e-04 | 8 | 47 | 2 | PF16214 | |
| Domain | Retinoid-X_rcpt/HNF4 | 2.75e-04 | 10 | 47 | 2 | IPR000003 | |
| Domain | - | 3.97e-04 | 57 | 47 | 3 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 4.18e-04 | 58 | 47 | 3 | IPR013088 | |
| Domain | A/G_cyclase_CS | 8.23e-04 | 17 | 47 | 2 | IPR018297 | |
| Domain | Chromodomain_CS | 9.24e-04 | 18 | 47 | 2 | IPR023779 | |
| Domain | Nucleotide_cyclase | 9.24e-04 | 18 | 47 | 2 | IPR029787 | |
| Domain | - | 9.24e-04 | 18 | 47 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.03e-03 | 19 | 47 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 1.03e-03 | 19 | 47 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.03e-03 | 19 | 47 | 2 | PS50125 | |
| Domain | A/G_cyclase | 1.03e-03 | 19 | 47 | 2 | IPR001054 | |
| Domain | CYCc | 1.03e-03 | 19 | 47 | 2 | SM00044 | |
| Domain | Chromo_domain | 1.65e-03 | 24 | 47 | 2 | IPR023780 | |
| Domain | Chromo | 1.94e-03 | 26 | 47 | 2 | PF00385 | |
| Domain | HECT | 2.09e-03 | 27 | 47 | 2 | PF00632 | |
| Domain | HECTc | 2.09e-03 | 27 | 47 | 2 | SM00119 | |
| Domain | HECT_dom | 2.09e-03 | 27 | 47 | 2 | IPR000569 | |
| Domain | HECT | 2.09e-03 | 27 | 47 | 2 | PS50237 | |
| Domain | CHROMO_1 | 2.25e-03 | 28 | 47 | 2 | PS00598 | |
| Domain | CHROMO_2 | 2.25e-03 | 28 | 47 | 2 | PS50013 | |
| Domain | SNF2_N | 2.93e-03 | 32 | 47 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 2.93e-03 | 32 | 47 | 2 | IPR016197 | |
| Domain | SNF2_N | 2.93e-03 | 32 | 47 | 2 | PF00176 | |
| Domain | Chromo/shadow_dom | 3.11e-03 | 33 | 47 | 2 | IPR000953 | |
| Domain | CHROMO | 3.11e-03 | 33 | 47 | 2 | SM00298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.50e-03 | 35 | 47 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.11e-03 | 38 | 47 | 2 | PS00690 | |
| Domain | zf-C4 | 5.98e-03 | 46 | 47 | 2 | PF00105 | |
| Domain | Znf_hrmn_rcpt | 5.98e-03 | 46 | 47 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 5.98e-03 | 46 | 47 | 2 | IPR001723 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.98e-03 | 46 | 47 | 2 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.98e-03 | 46 | 47 | 2 | PS00031 | |
| Domain | ZnF_C4 | 5.98e-03 | 46 | 47 | 2 | SM00399 | |
| Domain | - | 6.23e-03 | 47 | 47 | 2 | 1.10.565.10 | |
| Domain | HOLI | 6.49e-03 | 48 | 47 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 6.49e-03 | 48 | 47 | 2 | IPR000536 | |
| Domain | Hormone_recep | 6.49e-03 | 48 | 47 | 2 | PF00104 | |
| Pathway | WP_TYPE_III_INTERFERON_SIGNALING | 2.98e-04 | 10 | 37 | 2 | M39464 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 2.98e-04 | 10 | 37 | 2 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 2.98e-04 | 10 | 37 | 2 | MM14668 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 5.98e-04 | 14 | 37 | 2 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 5.98e-04 | 14 | 37 | 2 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 6.89e-04 | 15 | 37 | 2 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 6.89e-04 | 15 | 37 | 2 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 6.89e-04 | 15 | 37 | 2 | M47504 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 7.86e-04 | 16 | 37 | 2 | M39849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 7.86e-04 | 16 | 37 | 2 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 7.86e-04 | 16 | 37 | 2 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 7.86e-04 | 16 | 37 | 2 | MM14492 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 8.89e-04 | 17 | 37 | 2 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 8.89e-04 | 17 | 37 | 2 | M47544 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.24e-03 | 20 | 37 | 2 | M759 | |
| Pathway | REACTOME_OTHER_INTERLEUKIN_SIGNALING | 1.78e-03 | 24 | 37 | 2 | M27385 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.78e-03 | 24 | 37 | 2 | M47520 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 2.09e-03 | 26 | 37 | 2 | M27750 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.09e-03 | 26 | 37 | 2 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.09e-03 | 26 | 37 | 2 | MM14495 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 2.26e-03 | 27 | 37 | 2 | M27632 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 2.26e-03 | 27 | 37 | 2 | MM15537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.26e-03 | 27 | 37 | 2 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.26e-03 | 27 | 37 | 2 | M47519 | |
| Pathway | KEGG_MELANOGENESIS | 2.32e-03 | 101 | 37 | 3 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.32e-03 | 101 | 37 | 3 | M1979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 2.43e-03 | 28 | 37 | 2 | M47647 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.60e-03 | 105 | 37 | 3 | MM15206 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.60e-03 | 29 | 37 | 2 | M47515 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 2.60e-03 | 29 | 37 | 2 | MM15340 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 2.60e-03 | 29 | 37 | 2 | M47627 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 2.78e-03 | 30 | 37 | 2 | M27637 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 2.97e-03 | 31 | 37 | 2 | M48258 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.97e-03 | 31 | 37 | 2 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.16e-03 | 32 | 37 | 2 | M47506 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.20e-03 | 113 | 37 | 3 | M27471 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.36e-03 | 115 | 37 | 3 | M9387 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 3.36e-03 | 33 | 37 | 2 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 3.36e-03 | 33 | 37 | 2 | M11575 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 10072763 | ||
| Pubmed | Expression of estrogen-related receptors in ovarian cancer and impact on survival. | 1.87e-06 | 2 | 48 | 2 | 34089362 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 19631715 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 27725180 | ||
| Pubmed | Estrogen-related receptor γ regulates hepatic triglyceride metabolism through phospholipase A2 G12B. | 1.87e-06 | 2 | 48 | 2 | 30922124 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 15598686 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 29888756 | ||
| Pubmed | The Structural Basis for Class II Cytokine Receptor Recognition by JAK1. | 5.59e-06 | 3 | 48 | 2 | 27133025 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.11e-05 | 212 | 48 | 5 | 33853758 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 9326634 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 18039682 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 29940916 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 18509053 | ||
| Pubmed | Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. | 1.86e-05 | 5 | 48 | 2 | 23676496 | |
| Pubmed | Parkin degrades estrogen-related receptors to limit the expression of monoamine oxidases. | 2.79e-05 | 6 | 48 | 2 | 21177257 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 16439465 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 23836911 | ||
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 38109525 | ||
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 5.19e-05 | 8 | 48 | 2 | 10655032 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 23743675 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 6.67e-05 | 9 | 48 | 2 | 17229090 | |
| Pubmed | A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. | 6.67e-05 | 9 | 48 | 2 | 16728976 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 34029594 | ||
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 6.67e-05 | 9 | 48 | 2 | 9417641 | |
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 12503609 | ||
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 8.33e-05 | 10 | 48 | 2 | 8663304 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 8.33e-05 | 10 | 48 | 2 | 11884542 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 16615126 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 10089566 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 10808179 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 11299302 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.07e-04 | 341 | 48 | 5 | 32971831 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 36542664 | ||
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 22560079 | ||
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 1.22e-04 | 12 | 48 | 2 | 9611134 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 10807185 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 20085599 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 16428440 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 1.68e-04 | 14 | 48 | 2 | 14993377 | |
| Pubmed | NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. | 1.68e-04 | 14 | 48 | 2 | 25150861 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.83e-04 | 608 | 48 | 6 | 36089195 | |
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 12183685 | ||
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 7937899 | ||
| Pubmed | DLX1 and the NuRD complex cooperate in enhancer decommissioning and transcriptional repression. | 1.94e-04 | 15 | 48 | 2 | 35695185 | |
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 1.94e-04 | 15 | 48 | 2 | 2165385 | |
| Pubmed | NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. | 1.94e-04 | 15 | 48 | 2 | 19927129 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 17567809 | ||
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 31315026 | ||
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 2.75e-04 | 91 | 48 | 3 | 20362542 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 10444591 | ||
| Pubmed | SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression. | 2.81e-04 | 18 | 48 | 2 | 29996942 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 9790534 | ||
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 24376456 | ||
| Pubmed | 4.63e-04 | 23 | 48 | 2 | 24349082 | ||
| Pubmed | 4.64e-04 | 469 | 48 | 5 | 27634302 | ||
| Pubmed | Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. | 5.05e-04 | 24 | 48 | 2 | 18454139 | |
| Pubmed | Decoding type I and III interferon signalling during viral infection. | 6.40e-04 | 27 | 48 | 2 | 30936491 | |
| Pubmed | 7.37e-04 | 1442 | 48 | 8 | 35575683 | ||
| Pubmed | Specification of dopaminergic subsets involves interplay of En1 and Pitx3. | 8.45e-04 | 31 | 48 | 2 | 23863478 | |
| Pubmed | 8.45e-04 | 31 | 48 | 2 | 12626323 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 8.45e-04 | 31 | 48 | 2 | 31550482 | |
| Pubmed | Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells. | 9.01e-04 | 32 | 48 | 2 | 25757744 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 1.13e-03 | 331 | 48 | 4 | 19490893 | |
| Pubmed | 1.27e-03 | 38 | 48 | 2 | 28680062 | ||
| Pubmed | 1.27e-03 | 38 | 48 | 2 | 33283408 | ||
| Pubmed | 1.27e-03 | 38 | 48 | 2 | 27820600 | ||
| Cytoband | 10q22.1 | 1.08e-03 | 46 | 48 | 2 | 10q22.1 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.53e-04 | 10 | 34 | 2 | 53 | |
| GeneFamily | Nuclear hormone receptors | 3.82e-03 | 49 | 34 | 2 | 71 | |
| Drug | clenbuterol | 5.24e-07 | 142 | 48 | 6 | CID000002783 | |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; HL60; HT_HG-U133A | 3.85e-06 | 200 | 48 | 6 | 3030_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.85e-06 | 200 | 48 | 6 | 3714_UP | |
| Drug | N'-((1E)-(4-(diethylamino)phenyl)methylene)-4-hydroxybenzohydrazide | 4.35e-06 | 2 | 48 | 2 | ctd:C501618 | |
| Disease | Prostatic Neoplasms | 4.71e-04 | 616 | 48 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.71e-04 | 616 | 48 | 6 | C0376358 | |
| Disease | neutrophil percentage of granulocytes | 5.17e-04 | 228 | 48 | 4 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 5.70e-04 | 234 | 48 | 4 | EFO_0007996 | |
| Disease | azoospermia (implicated_via_orthology) | 8.86e-04 | 27 | 48 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 1.41e-03 | 34 | 48 | 2 | DOID:5082 (biomarker_via_orthology) | |
| Disease | dyslexia | 2.34e-03 | 162 | 48 | 3 | EFO_0005424 | |
| Disease | attempted suicide | 3.06e-03 | 178 | 48 | 3 | EFO_0004321 | |
| Disease | executive function measurement | 3.25e-03 | 376 | 48 | 4 | EFO_0009332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CMGSIKENKCLLMSF | 71 | P19397 | |
| FKICMKMCLLQITGY | 91 | Q8IZ81 | |
| LIFANKQDMKGCMTA | 121 | Q96KC2 | |
| MKCLSLLKFLMDLGC | 486 | Q96Q27 | |
| NCVKMGLDMCQAIKQ | 346 | P51828 | |
| SGFLNIMMELKKCCN | 746 | O14646 | |
| NCSAMFGKLMTIAKN | 531 | Q29RF7 | |
| MCKKCMELISLPLAN | 186 | Q9H1K0 | |
| IKEDCNAMAFCAKMR | 6 | P23458 | |
| CMGAIKCQLNLDILM | 96 | O60330 | |
| GDKFFLKNNMILCQM | 126 | P25800 | |
| IMCENCMTTNQKKAL | 436 | Q86YP4 | |
| MGLDKMKKTACGFCF | 71 | P52298 | |
| GTKELLCSMMCLKKQ | 76 | Q8IU57 | |
| LCSMMCLKKQDLYNK | 81 | Q8IU57 | |
| GIMFINKCATCKMIL | 56 | Q9NQ38 | |
| KMHINKCAMCQSIFD | 876 | Q9NQ38 | |
| CLLMPQCNAFLSKIM | 331 | Q5HYC2 | |
| MAGKSMQLLKNLQCA | 561 | Q96RT8 | |
| MDLGIPAMTKCCNQL | 101 | Q9BX93 | |
| QMKDLNNMKITFCCP | 966 | Q9UII4 | |
| CKMNNQTKTLDCLMA | 481 | Q9ULW2 | |
| KNCVKMGLDMCEAIK | 356 | Q08462 | |
| QKMAQENMCCDKSGF | 251 | Q86Z20 | |
| IMVIMKDPCFAKCQN | 591 | O94808 | |
| CDGELLFNMTKKMCC | 1706 | P35555 | |
| LFNMTKKMCCCSYNI | 1711 | P35555 | |
| KQMECKNLIGTYMCI | 2261 | P35555 | |
| VSLLNIMMDLKKCCN | 1016 | Q12873 | |
| QACRFMKCLKVGMLK | 181 | P62508 | |
| QACRFMKCLKVGMLK | 156 | O95718 | |
| NMLCPDCAKRNKKMM | 276 | Q7Z7J5 | |
| MNKQFQACIMKMVCG | 306 | P03999 | |
| LAKMAAVSKACGNMF | 296 | P49903 | |
| MKGCLNMRTQKCYAV | 476 | O15457 | |
| MSECLLKAMLNCKTF | 291 | Q8N5C6 | |
| KRSCALQMKYCQAFM | 86 | Q6UXN8 | |
| NCSEIICMFNNMGKI | 291 | Q9BXT8 | |
| KKKEMLQMVCAQCHG | 106 | Q8N6M9 | |
| DCSGACLMKMPLNLK | 146 | Q96T68 | |
| YKAMNIGCMENLKAL | 61 | Q9UHP6 | |
| LQNDGKCCPFMESML | 591 | Q6ZVD7 | |
| VQGNPMKLRCISCMK | 36 | Q9NY72 | |
| ECSKMFPKLTKNMLC | 221 | Q6UWB4 | |
| ESKQLLAMLMLFCDC | 521 | Q7Z3V4 | |
| RSQCMQLVGDCLMKA | 1936 | O43149 | |
| QGNFMIKMKLSCLVN | 186 | Q9P2L0 | |
| KQFMCQWCGKDFNMK | 411 | Q9Y2D9 | |
| VQMCKMKAFGELCPN | 436 | Q70J99 | |
| LFSQIGPCKNCKMIM | 26 | P31483 | |
| GFRKEKAKMDMCCAA | 756 | Q9H0D2 | |
| GVDKNKFCDLCNMMF | 116 | Q5H9K5 | |
| LFLRKDMCSCRKGMQ | 1591 | Q9NQX4 |